PTX3 and central nervous system cancer: Increased circulating levels of PTX3 were observed in myeloproliferative neoplasms [57], lung cancers [58, 59], soft tissue sarcomas [60], gliomas [61], pancreatic and hepatocellular carcinomas [62, 63].